The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach $1,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the investors/venture capitalists as the developed markets are saturated. The presence of noteworthy developments by China and Japan for integration of new technologies and the development of healthcare is majorly driving the Asia Pacific Market.
R&D and clinical development frameworks of countries such as India and Australia have composed the Asia Pacific market to witness a lucrative growth throughout the forecast period.
Key players in Asia Pacific Next Generation Sequencing Market include Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer inc., DNASTAR Inc., and Qiagen N.V.
Rise in growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, increasing research in oncology are few factors driving the market growth. In addition, anticipated decrease in the prices of genome sequencing due to development
of rapid, high capacity whole genome sequencers by key players is expected to have an optimistic effect on market penetration rates over the few years. However, the storage and management of enormous data generated by sequencing and its interpretation, high reliability on grants & funding
from the government and fall in capital expenditure from academic institutions are some of the challenges for Asia-Pacific next generation sequencing market
The Next Generation Sequencing market is categorized by type (product and services) and by technology such as whole targeted re-sequencing, genome sequencing, exome sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. And by application it is segmented into
diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research. Further, based on end users the market is segmented as Academic Institutions and Research Centers, Hospitals/Clinical Laboratories, Biotech/Pharma Companies and others.
On the basis of geography, the Asia-Pacific market is segmented into regions namely, China, India, Japan, South Korea, Taiwan, Indonesia, Malaysia, Singapore and Thailand. Asia-Pacific Next Generation Sequencing (NGS) Market
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/1051511-asia-pacific-next-generation-sequencing-ngs-market-by-product-software-and
Some Points from Table of content:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. RESEARCH METHODOLOGY
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. MARKET SEGMENTATION
5.2 APAC NGS Market, By Type
188.8.131.52 Instruments and Software
184.108.40.206 Y-o-Y Growth Analysis, By Product
220.127.116.11 Market Attractiveness Analysis, By Product
18.104.22.168 Market Share Analysis, By Product
If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/1051511-asia-pacific-next-generation-sequencing-ngs-market-by-product-software-and
For more information or any query mail at firstname.lastname@example.org
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym